Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma
Cancer Science · 2023-06 · 114 (6) · 2609-2621
DOI: 10.1111/cas.15773 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 10.03.2023. Verfasst von Haibin Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Glioblastomas are highly heterogeneous brain tumors. Despite the availability of standard treatment for glioblastoma multiforme (GBM), i.e., Stupp protocol, which involves surgical resection followed by radiotherapy and chemotherapy, glioblastoma remains refractory to treatment and recurrence is inevitable. Moreover, the biology of recurrent glioblastoma remains unclear. Increasing evidence has shown that intratumoral heterogeneity and the tumor microenvironment contribute to therapeutic resistance. However, the interaction between intracellular heterogeneity and drug resistance in recurrent GBMs remains controversial. The aim of this study was to map the transcriptome landscape of cancer cells and the tumor heterogeneity and tumor microenvironment in recurrent and drug‐resistant GBMs at a single‐cell resolution and further explore the mechanism of drug resistance of GBMs. We analyzed six tumor tissue samples from three patients with primary GBM and three patients with recurrent GBM in which recurrence and drug resistance developed after treatment with the standard Stupp protocol using single‐cell RNA sequencing. Using unbiased clustering, nine major cell clusters were identified. Upregulation of the expression of stemness‐related and cell‐cycle‐related genes was observed in recurrent GBM cells. Compared with the initial GBM tissues, recurrent GBM tissues showed a decreased proportion of microglia, consistent with previous reports. Finally, vascular endothelial growth factor A expression and the blood–brain barrier permeability were high, and the O 6 ‐methylguanine DNA methyltransferase‐related signaling pathway was activated in recurrent GBM. Our results delineate the single‐cell map of recurrent glioblastoma, tumor heterogeneity, tumor microenvironment, and drug‐resistance mechanisms, providing new insights into treatment strategies for recurrent glioblastomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
- Department of Biometric Information, Sun Yat-sen University Cancer Center, Guangzhou, China.
- Department of Neurosurgery, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
- Department of Medical Oncology, Binzhou Medical University Hospital, Binzhou, China.
ORCID-Profile: Haibin Wu, Qunying Yang
Förderung
- Natural Science Foundation of Guangdong Province
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Wu, H., Guo, C., Wang, C., Xu, J., Zheng, S., Duan, J., Li, Y., Bai, H., Xu, Q., Ning, F., Wang, F., & Yang, Q. (2023). Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma. Cancer Science, 114(6), 2609-2621. https://doi.org/10.1111/cas.15773
Vancouver
Wu H, Guo C, Wang C, Xu J, Zheng S, Duan J, et al. Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma. Cancer Science. 2023;114(6):2609-2621. doi:10.1111/cas.15773
BibTeX
@article{Wu2023,
author = {Wu, Haibin and Guo, Chengcheng and Wang, Chaoye and Xu, Jiang and Zheng, Suyue and Duan, Jian and Li, Yiyun and Bai, Hongming and Xu, Qiuyan and Ning, Fangling and Wang, Feng and Yang, Qunying},
title = {Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma},
journal = {Cancer Science},
year = {2023},
volume = {114},
number = {6},
pages = {2609--2621},
doi = {10.1111/cas.15773}
}
EUVIMED